Wikidata entity: Q7157043
C₂₁H₂₃N₇O₂S (P274)
Quantities
| P2067 | mass | 437.163394 |
| P3780 | active ingredient in | ... | Q29006670 (Votrient) | Votrient |
| P233 | canonical SMILES | String | CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N | ??? |
| P373 | Commons category | String | Pazopanib | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q3242950 (kidney cancer) | kidney cancer |
| P2175 | medical condition treated | ... | Q1164529 (renal cell carcinoma) | renal cell carcinoma |
| P2175 | medical condition treated | ... | Q1495661 (gastrointestinal stromal tumor) | gastrointestinal stromal tumor |
| P2175 | medical condition treated | ... | Q1989240 (renal pelvis carcinoma) | renal pelvis carcinoma |
| P2175 | medical condition treated | ... | Q2619315 (synovial sarcoma) | synovial sarcoma |
| P2175 | medical condition treated | ... | Q56014392 (rare urinary tract tumor) | rare urinary tract tumor |
| P2175 | medical condition treated | ... | Q5965479 (uterine sarcoma) | uterine sarcoma |
| P2175 | medical condition treated | ... | Q18553680 (connective tissue benign neoplasm) | connective tissue benign neoplasm |
| P2175 | medical condition treated | ... | Q18556340 (renal clear cell carcinoma) | renal clear cell carcinoma |
| P2175 | medical condition treated | ... | Q18556721 (uterus leiomyosarcoma) | uterus leiomyosarcoma |
| P129 | physically interacts with | ... | Q909409 (KIT proto-oncogene, receptor tyrosine kinase) | KIT proto-oncogene, receptor tyrosine kinase |
| P129 | physically interacts with | ... | Q21118353 (fms related receptor tyrosine kinase 4) | fms related receptor tyrosine kinase 4 |
| P129 | physically interacts with | ... | Q21172390 (kinase insert domain receptor) | kinase insert domain receptor |
| P129 | physically interacts with | ... | Q5446453 (fibroblast growth factor receptor 1) | fibroblast growth factor receptor 1 |
| P129 | physically interacts with | ... | Q21100975 (Colony stimulating factor 1 receptor) | Colony stimulating factor 1 receptor |
| P129 | physically interacts with | ... | Q21108624 (Platelet derived growth factor receptor beta) | Platelet derived growth factor receptor beta |
| P129 | physically interacts with | ... | Q21115605 (Fms related receptor tyrosine kinase 1) | Fms related receptor tyrosine kinase 1 |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q411159 (famotidine) | famotidine |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q906453 (posaconazole) | posaconazole |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q5473363 (fosphenytoin) | fosphenytoin |
| P769 | significant drug interaction | ... | Q5908266 (idelalisib) | idelalisib |
| P9989 | stylized name | String | PAZOPanib | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q7251487 (protein kinase inhibitors) | protein kinase inhibitors |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | pazopanib | ??? |
Why not click here or view trends?
log id: 2083083